Technical Analysis for ABT - Abbott Laboratories

Grade Last Price % Change Price Change
grade C 84.54 -1.19% -1.02
ABT closed down 1.19 percent on Tuesday, August 20, 2019, on 66 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Down Down
See historical ABT trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
Crossed Above 50 DMA Bullish -1.19%
Narrow Range Bar Range Contraction -1.19%
NR7 Range Contraction -1.19%
NR7-2 Range Contraction -1.19%
Gapped Up Strength -1.19%
50 DMA Resistance Bearish -0.28%
Narrow Range Bar Range Contraction -0.28%
NR7 Range Contraction -0.28%

Older signals for ABT ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, pain, fever, inflammation, hypothyroidism, gynecological disorders, intrahepatic cholestasis or depressive symptoms, physiological rhythm of the colon, dyslipidemia, and hypertension, as well as provides anti-infective and influenza vaccines. The company's Diagnostic Products segment provides diagnostic systems and tests, such as immunoassay and clinical chemistry systems; assays for screening and diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, and physiological and infectious diseases; genomic-based tests; hematology systems and reagents; and diagnostic systems and tests for blood analysis, as well as instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents. Its Nutritional Products segment offers pediatric and adult nutritional products comprising various forms of prepared infant and follow-on formula. The company's Vascular Products segment provides coronary, endovascular, vessel closure, and structural heart devices for the treatment of vascular disease. Abbott Laboratories also offers blood glucose monitoring meters, test strips, and data management software and accessories for people with diabetes; and medical devices for the eye, including cataract surgery, LASIK surgery, contact lens care products, and dry eye products. The company primarily serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.
Medicine Cancer Life Sciences Pain Diabetes Inflammation Illinois Influenza Hypertension Health Care Products Cataract Dyslipidemia Irritable Bowel Syndrome Fever Vascular Disease Cataract Surgery Generic Pharmaceuticals Cholestasis Data Management Software Hypothyroidism
Is ABT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 88.76
52 Week Low 64.477
Average Volume 5,055,499
200-Day Moving Average 77.071
50-Day Moving Average 85.1406
20-Day Moving Average 85.9645
10-Day Moving Average 85.107
Average True Range 1.7018
ADX 25.96
+DI 17.8163
-DI 26.3758
Chandelier Exit (Long, 3 ATRs ) 83.65460000000001
Chandelier Exit (Short, 3 ATRs ) 87.4154
Upper Bollinger Band 89.241
Lower Bollinger Band 82.688
Percent B (%b) 0.28
BandWidth 7.622914
MACD Line -0.1352
MACD Signal Line 0.1135
MACD Histogram -0.2487
Fundamentals Value
Market Cap 146.88 Billion
Num Shares 1.74 Billion
EPS 0.71
Price-to-Earnings (P/E) Ratio 119.07
Price-to-Sales 4.08
Price-to-Book 3.05
PEG Ratio 1.87
Dividend 1.06
Dividend Yield 1.25%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 86.84
Resistance 3 (R3) 87.07 86.54 86.45
Resistance 2 (R2) 86.54 85.96 86.42 86.32
Resistance 1 (R1) 85.54 85.59 85.28 85.31 86.20
Pivot Point 85.01 85.01 84.88 84.89 85.01
Support 1 (S1) 84.01 84.43 83.75 83.78 82.88
Support 2 (S2) 83.48 84.06 83.36 82.76
Support 3 (S3) 82.48 83.48 82.63
Support 4 (S4) 82.25